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In contrast to animal-based mutant phenotype assays, recent biochemical and quantitative 
genetic studies have identified hundreds of potential regulators of known signaling path-
ways. We discuss the discrepancy between previous models and new data, put forward a 
different signaling conceptual framework incorporating time-dependent quantitative contri-
butions, and suggest how this new framework can impact our study of human disease.Cell biology and biochemistry have 
provided insights into the mecha-
nistic understanding of the nature, 
location, and kinetics of the protein 
interactions underlying signal trans-
duction. The identity of proteins that 
transduce signals within cells origi-
nates, in part, from forward genetic 
screens in model organisms in addi-
tion to biochemical techniques. For 
example, in the fruit fly Drosophila, 
arguably the most successful 
genetic screens were the early 
large screens isolating genes that, 
when mutated, were associated 
with embryonic lethality and strik-
ing changes in cuticle morphology 
(Nusslein-Volhard and Wieschaus, 
1980). The outcome of these screens 
was that genes with similar visible 
morphological mutant phenotypes 
were subsequently found to be 
involved in the same signaling path-
way. Later screens using mosaic 
techniques, overexpression, and 
sensitized genetic backgrounds and 
concurrent biochemical approaches 
completed the current list of signal-
ing components.
Extensive signaling studies have 
yielded a limited repertoire of canoni-
cal signaling pathways, including the 
Wingless/Wnt, Hedgehog, receptor 
tyrosine kinase/extracellular regu-
lated kinase (RTK/ERK), Akt/Tor, 
Jak-STAT, Notch, TGFβ, G protein-
coupled receptor (GPCR), NF-κB, 
Toll, and steroid hormone pathways. 
Since the discovery of founding members of these pathways, new 
components continue to be identified 
steadily either through biochemistry 
or genetic screening.
The current dominant model for 
signal transduction is that of a sign-
aling pathway, a cassette consisting 
of tens of proteins, compartmental-
ized, hierarchical, and independent 
from the rest of the proteome. These 
pathways are frequently depicted in 
the literature as wiring diagrams with 
linear flows from the input signal, 
through the cascade of reactions, 
to the output. The analogy, either 
implicitly or explicitly, is that of an 
electrical circuit. Although cell biolo-
gists have long recognized that some 
connections between pathway com-
ponents and other pathways appear 
in particular cell types, this crosstalk 
is relatively limited and dependent 
upon the circuit models that rarely 
consider the dynamic and quantita-
tive contributions of individual com-
ponents. This canonical pathway 
model has been extremely useful as 
an organizational and didactic tool 
to explain the properties of some 
biological systems. However, the 
limited linear conceptual framework 
determines how these pathways are 
studied and implicated in human 
disease states. Therefore, new mod-
els may be necessary to respond to 
emerging technologies that suggest 
a very different view of signal trans-
duction and thus the pathophysiol-
ogy of disease.Cell 128, JA New Look at Signaling
The wealth of genetic and biochemi-
cal data suggests two major revisions 
to the traditional, canonical view of 
signaling pathways: (1) a massive 
increase in the number of compo-
nents linked to a particular pathway 
and (2) an appreciation for the vari-
able quantitative contribution of each 
of these new components to dynamic 
signal propagation.
Systematic yeast two-hybrid 
and coimmunoprecipitation assays 
to explore several eukaryotic pro-
teomes—including those of the bud-
ding yeast Saccharomyces cerevi-
siae, fruit fly D. melanogaster, worm 
Caenorhabditis elegans, and human—
have revealed thousands of new 
protein complexes and connections 
among many functionally unannotated 
proteins (for example, see Giot et al., 
2003; Krogan et al., 2006). These data 
collectively suggest that cellular proc-
esses are orchestrated by a much 
larger protein network than previously 
thought. As most of these screens 
are neither saturating nor within 
endogenous signaling contexts, this 
conclusion is likely to be revised and 
expanded in the near future.
Unbiased genetic studies have 
provided validation that these new 
interactions are often functionally rel-
evant and frequently demonstrate an 
even wider collection of genes that 
affect previously well-defined simple 
processes. Synthetic genetic array 
(SGA) analysis of yeast single-gene anuary 26, 2007 ©2007 Elsevier Inc. 225
Figure 1. Continuous Distributions of Quantitative Signaling Readouts
(A) Quantitative assay for ERK activation in a cell-based Drosophila RNAi screen (Friedman and Perrimon, 2006). Effect of each double-stranded 
RNA is represented as a Z score relative to control ERK activation. 
(B) In vivo quantitative P element collection screen in Drosophila assaying deviation of bristle number (Norga et al., 2003). 
(C) Genome-wide quantitative deletion screen for G protein/MAPK signaling in S. cerevisiae (Chasse et al., 2006). Effect of each deletion on mating 
factor stimulation relative to an internal wild-type control. Unpublished dataset is courtesy of H. Dohlman.deletions suggests that 10%–50% 
of genes without a significant effect 
on growth alone may have a synthetic 
genetic interaction growth phenotype 
(Tong et al., 2004). In yeast meta-
bolic systems, although only 13% 
of metabolic genes are essential by 
single-gene knockout studies, com-
putational methods demonstrate 
that 74% of the genes contribute to 
metabolic function (Deutscher et 
al., 2006). Advances in RNA inter-
ference (RNAi) technology, notably 
the recent creation of genome-wide 
RNAi screening libraries, have helped 
to speed up the rate of gene discov-
ery. Similar to the SGA studies in 
yeast, synthetic genetic RNAi inter-
actions between disease-relevant 
mutations in C. elegans and ?1750 
genes similarly uncovered new roles 
for genes in signaling (Lehner et al., 
2006). Although C. elegans screens 
often assay developmental pheno-
types, Drosophila and mammalian 
RNAi screens are performed in cell 
culture, with many of these focused 
on dissecting the major signaling 
pathways. A hallmark of these RNAi 
screens is that the number of new hits 
is in the hundreds. As an example of 
the application of genome-wide RNAi 
screening technology to signaling, 
we recently completed a screen for 
regulators of ERK/MAPK activity fol-
lowing RTK stimulation and identified 
331 potential regulators of RTK/ERK 
(Friedman and Perrimon, 2006). This 
rapid expansion of functional anno-226 Cell 128, January 26, 2007 ©2007 Etation provides a starting point for 
detailed mechanistic analyses of the 
new regulators in the setting of ani-
mal development and disease.
As cell-based RNAi screens for 
signaling pathways use quantitative 
pathway reporters, genome-wide 
screens can also reveal the individual 
contribution of each gene to the sign-
aling output, as measured at the given 
point in the pathway. This can be best 
understood by observing total assay 
distribution plots that rank the score 
of each double-stranded RNA tested 
(and thus the contribution of each 
gene when knocked down) from the 
strongest positive to the strongest 
negative regulators (Figure 1A). An 
under-appreciated feature of these 
distributions is that, strikingly, they 
are continuous functions. Frequently 
the known canonical components 
are the strongest regulators, but, 
unexpectedly, they are not a discrete 
cluster. Sequence-specific off-target 
effects associated with long double-
stranded RNAs used in these RNAi 
screens (Kulkarni et al., 2006; Ma et 
al., 2006) may contribute to this distri-
bution. However, in our view, curation 
of false positives from the assay dis-
tributions may not change the over-
all picture of a continuous function 
for proteome regulation of particular 
pathways.
Given concern over RNAi off-target 
effects, it is important to note that 
continuous distributions of genetic 
contributions to signaling output lsevier Inc.have also been observed in systems 
other than Drosophila cells and RNAi, 
as long as a quantitative trait is being 
measured. Examples include sev-
eral mammalian overexpression and 
RNAi screens, a quantitative screen 
for defects in bristle number in Dro-
sophila (Norga et al., 2003), a process 
linked to Notch and EGFR signaling 
(Figure 1B), and a genome-wide gene 
deletion screen in yeast for modifi-
ers of the mating-type response sig-
naled by G protein/MAPK pathways 
(Chasse et al., 2006) (Figure 1C). The 
emerging view is that there is not a 
specific number of regulators of a 
pathway. In fact, the definitions of a 
finite number of potential hits in such 
screens (e.g., 331) are based on arbi-
trary thresholds frequently used for 
practical reasons.
Recent data from systematic unbi-
ased biochemical and genetic experi-
ments and cell-based, pathway-spe-
cific quantitative functional genomic 
screens argue (1) against signaling 
pathways as being limited to a hand-
ful of canonical components and (2) 
that the large regulatory network has 
a graded effect on signaling output.
Genetic Screens and Robustness
If recent technological advances 
suggest a newer model of signal 
transduction cascades, perhaps our 
current view is an artificial product 
of previous methodologies used to 
identify and organize them—namely, 
traditional mutagenesis screens for 
developmental defects. How have 
developmental screens in model 
organisms yielded a different view of 
signaling than that arising from unbi-
ased quantitative screens?
The difference between animal 
and cellular activity-based screens 
may reflect the robustness of bio-
logical networks. Signaling networks 
underlying animal development are 
well-known examples of robust-
ness in biology (Stelling et al., 2004; 
Wagner, 2005)—that is, the develop-
mental vector toward the wild-type 
is highly resistant to both extrinsic 
(environmental influences such as 
temperature) and intrinsic (muta-
tions) perturbations. Examples of 
robustness (alternatively called buff-
ering or decoupling) can be dramatic: 
Drosophila embryos from females 
with five additional copies of the 
bicoid gene have an enlarged head 
and compressed parasegments but, 
amazingly, develop into “fairly nor-
mal” adults (Busturia and Lawrence, 
1994). Robustness is a long-recog-
nized phenomenon, a generalization 
of Waddington’s “canalization” of ani-
mal development: “the genotype can, 
as it were, absorb a certain amount 
of its own variation without exhibit-
ing any alteration in development” 
(Waddington, 1942). An alternative 
view of robustness is that develop-
mental signaling networks inhabit a 
large neutral space of qualitative out-
put, tolerating quantitatively meas-
urable differences without affecting 
the end-point phenotype (Wagner, 
2005). Technological advances have 
enabled explicit experimental and 
computational investigation of Wad-
dington’s strikingly prescient insights 
revealing extensive robustness in cell 
growth and metabolism.
Both theoretical and experimental 
studies have identified multiple poten-
tial sources of robustness, including 
modularity and redundancy, network 
architecture, and feedback control 
(Stelling et al., 2004). Redundancy of 
individual genes or modules of groups 
of proteins is a relatively straightfor-
ward mechanism to buffer genetic 
change. Theoretically, the structure of 
biological networks, such as protein-
protein interaction networks, provides some resistance to perturbation. The 
probability that a given node in nearly 
all of these biological networks has 
a particular number of links to oth-
ers follows a power law distribution, 
referred to as a scale-free network 
(Barabasi and Oltvai, 2004). A conse-
quence of this structure is that ran-
dom attacks (mutations) have little 
effect as most genes affect few oth-
ers, but an attack on a hub can cause 
a dramatic breakdown, that is, a vast 
increase in network path length. It is 
likely, however, that the critical com-
ponent of robustness in signal trans-
duction is feedback control, as the 
information in signaling networks is 
propagated over time. For example, 
positive feedback ensures that weak 
input stimuli in the network evolve into 
discrete outputs (switch-like behav-
ior), whereas negative feedback con-
trol suppresses undesired stochastic 
effects on the final output.
Robustness toward one out-
come—the wild-type—is balanced 
by fragility to certain kinds of attacks 
(on feedback controls, for exam-
ple). Other robust characteristics of 
the network (such as other positive 
feedback loops) may remain after an 
attack and therefore can be hijacked 
in a cascading failure (Stelling et al., 
2004). The behavior of the attacked 
network may itself be robust, with an 
entirely abnormal outcome, and anal-
ysis or perturbation of this network 
may show little resemblance to the 
original network.
Given the robustness of signal-
ing networks, the success of genetic 
screens in elucidating a number of 
signaling pathways is surprising. 
Indeed, for a mutant to alter mor-
phology sufficiently to be observed, 
the developmental network has to be 
perturbed to cause complete break-
down. A decade ago, the special 
characteristics of zygotically lethal 
genes were appreciated in terms of 
developmental switches or controlling 
elements that logically had spatially 
restricted expression patterns (Wie-
schaus, 1996). Within the language of 
networks, genes that, when mutated, 
result in lethality must disrupt the 
robustness of developmental signal-
ing pathways. Thus, a special char-Cell 128, Jacteristic of these genes may be that 
they are hubs—a fragility in scale-free 
networks. In support of this model, in 
yeast, essential genes are among the 
most highly connected in the global 
protein interaction network (Barabasi 
and Oltvai, 2004; Krogan et al., 2006). 
However, recent studies question this 
“centrality-lethality” concept. Hubs 
can be separated into those that tend 
to be coexpressed with their interac-
tion partners (“party” or intramodule 
hubs) or not coexpressed (“date” or 
intermodule hubs). Only attacks on 
date hubs have dramatic effects on 
network path length despite both 
types being equally essential, and 
so network connectivity can be 
uncoupled from the essentialness of 
proteins (Han et al., 2004). Reinter-
preting network architecture within 
a dynamic context (correlated gene 
expression) provides a more compli-
cated view of centrality-lethality. Fur-
ther inclusion of dynamics within the 
timescale of signaling—for example, 
seconds and minutes—may refine 
the contribution of network architec-
ture to signaling robustness. Within 
this context, robustness imparted by 
feedback control may be more com-
pelling. Mutations in genes outside 
of major canalizing feedback loops 
may have little effect because these 
loops maintain the same quantita-
tive output of the overall intercellular 
network, even if mutation of the gene 
does cause quantitative effects when 
measured elsewhere in the intrac-
ellular network. On the other hand, 
mutation of genes that break major 
feedback loops destroy the canaliz-
ing forces. Thus, genes with similar 
lethal, morphologically mutant end-
points have been closely associated 
within networks as pathways. Other, 
similarly “close” regulators of that 
network with slightly different con-
nections within feedback loops may 
have different, but not recognizable, 
outcomes.
Even if the genetic buffering of 
particular mutations is not complete, 
another major cause of the failure to 
identify other potential pathway regu-
lators is pleiotropy. Pleiotropic genes 
either function in multiple pathways 
(e.g., casein kinase and protein anuary 26, 2007 ©2007 Elsevier Inc. 227
Figure 2. Traditional Developmental and Recent Cell-Based Views of Signaling
(A) Simplified cell circuit diagram for a signaling pathway depicting a few, compartmentalized 
components without quantitative information. 
(B) Network model for signaling. Following a stimulus, information is propagated throughout the 
network, leading to multiple outputs. Relative contribution, or flow rate, of each protein to the 
maximal output is represented by line weights (thicker implies larger contribution of that protein or 
interaction to the output). Canonical components (blue) from genetic screens may make many of 
the quantitatively significant connections, as measured at a particular protein within the network. 
Model complexity is magnified when quantitative contributions are considered in the context of 
multiple signals. 
(C) Mutant developmental phenotypes may appear only at the extremes of genetic contribution 
to the signaling pathway due to robustness. Shown is the correlation between extreme positive Z 
scores (negative regulators) in an RTK/ERK screen (Friedman and Perrimon, 2006) and a gain-of-
function (GOF) Torso RTK phenotype (torY9) and extreme negative Z scores (positive regulators) 
and a loss-of-function (LOF) Torso phenotype (tor−/−). All other gene contributions are buffered by 
the developmental context and appear as wild-type (WT). 
(D) Relationship between cell-based quantitative screen output and a network signaling model. 
In this screen, canonical components have the greatest impact on signaling output and thus are 
represented at the extreme ends of the distribution. More distant and quantitatively less impor-
tant proteins appear internally along the distribution. Measuring signaling output at one of these 
proteins may result in canonical components having weak effects in the assay. 
(Images in panel C courtesy of Willis Li.)phosphatase 2A family members) or 
are used in modules that are rede-
ployed multiple times (e.g., MEK act-
ing downstream of RTKs). Because 
developmental outcomes were used 
in traditional genetic screens, the role 
of a pleiotropic gene may be obscured 
by an earlier, perhaps unrecognizable 
phenotype. Lastly, proteins that are 
party hubs or components of feed-228 Cell 128, January 26, 2007 ©2007 Eback circuits may genuinely interact 
with and control many other genes 
or proteins in a single pathway and 
therefore result in phenotypes when 
attacked. On the other hand, genes 
such as heat-shock proteins or gen-
eral transcription factors, while con-
nected to many other proteins and 
modifiers of multiple networks, may 
not transmit information among lsevier Inc.them (they have unidirectional infor-
mation flow). These latter genes are 
expected to be pleiotropic and may 
correspond in part to intermodule 
date hubs; indeed, genetic interac-
tions among date hubs are twice as 
likely as party hubs (Han et al., 2004). 
Given that hubs are more likely than 
non-hubs to result in phenotypes 
when attacked, some proportion of 
these may be pleiotropic and thus 
missed during genetic screening.
Experimental evidence supports 
widespread pleiotropy. Heat-shock 
protein Hsp90 was one of the first 
experimentally defined genetic buff-
ers for morphological variation (Ruth-
erford and Lindquist, 1998). More 
recently, the C. elegans RNAi screen 
for modifiers of disease-linked path-
way genes reached the same con-
clusion: genetic buffers including 
general transcriptional machinery 
can modify multiple disease-linked 
pathway mutants in vivo (Lehner et 
al., 2006). A study of cell growth in 
yeast revealed that pleiotropy may be 
much more common than is appreci-
ated: 216 out of 767 deletion strains 
affected growth under more than two 
conditions (Dudley et al., 2005). An 
assay for wing shape in Drosophila 
found that mutations in genes nomi-
nally in the same pathway had dis-
tinct effects on morphology, implying 
that these genes do not operate in the 
same pathway to control wing shape, 
and hence “quantitative cross-talk 
between pathways may be complex” 
(Dworkin and Gibson, 2006).
More broadly, it is obvious that a 
screen for developmental morpho-
logical alteration must rely on phe-
notypes that are visible. Indeed, only 
580 out of 4500 mutations analyzed 
in the Drosophila embryonic lethal 
screens had a morphology that was 
sufficiently altered to be classified 
(Wieschaus, 1996). In addition, theo-
retically, mutant phenotypes may be 
more variable than the “constancy of 
the wild-type” (Waddington, 1942). 
Although not universal (Dworkin and 
Gibson, 2006), it may be true in some 
cases that mutant variability reduced 
the likelihood of further functional 
characterization by the investigator. 
More importantly, if regulators have a 
weaker quantitative effect on signal-
ing, they may not have been observed. 
Hence, assay sensitivity itself is a 
barrier to isolation of genes.
Thus, the practical constraints of 
traditional screening and pleiotropy 
may have led to the isolation of a few 
canonical pathway components. The 
robustness of biological networks 
transforms the continuous distribu-
tion of gene effects on signaling net-
works into discrete developmental 
outcomes in mutagenesis screens 
(Figure 2C).
New Methods to Study Signaling
If traditional genetic screening is 
unlikely to comprehensively identify 
new components of signaling net-
works, how can we uncover these 
links? Two major problems hinder 
this discovery: sensitivity and scale. 
The robust developmental network 
includes both intracellular signaling 
networks and intercellular commu-
nication and coordination. Devel-
opmental robustness, for which the 
final outcome is organismal organiza-
tion, is on a different scale than spe-
cific intracellular signaling networks, 
which may be able to buffer biochem-
ical noise but not abrogation of feed-
back control (Stelling et al., 2004). 
Such perturbations may or may not 
be buffered on the scale of multicel-
lular developmental morphogenesis. 
Thus, to identify new pathway regula-
tors, we must focus genetic screen-
ing below the layer of the canalizing 
elements, at the scale of the cellular 
network itself. In addition, screening 
should be sensitive and quantita-
tive rather than relying on discrete or 
qualitative outputs so that the relative 
contribution to the network can be 
appreciated.
Functional RNAi screening of sig-
naling networks using quantitative 
cell-based assays approaches this 
goal. Such assays using reporters 
measure output of specific signaling 
networks removed from the buffer-
ing developmental context. Phos-
pho-specific antibody assays, in par-
ticular, offer insight into the network 
signal level at specific points within 
the network, an advantage over tran-
scriptional reporters at the bottom of networks (their output). RNAi screen-
ing still suffers from time lags that may 
amplify network failure. However, the 
delay is necessary for depletion of 
the gene rather than the appearance 
of a phenotype.
Although the isolation of specific 
networks in cells may be an advan-
tage for identifying new pathway 
components, some may consider this 
system to be less relevant to signal-
ing in vivo. Perhaps another approach 
would be to perform quantitative 
in vivo genetic screening, such as 
done recently in Drosophila for bristle 
number (Norga et al., 2003) and wing 
shape (Dworkin and Gibson, 2006). 
Notably, when a sensitive quantitative 
trait is being measured, the resulting 
similarity of the assay score distribu-
tion plots for these in vivo screens 
and RNAi screens is striking (Figures 
1A and 1B), suggesting that nonca-
nonical proteins are also isolated in 
vivo as well as in cell culture. These 
studies using a collection of P-ele-
ment insertion lines could be per-
formed in a more systematic manner 
using a genome-wide collection of 
transgenic Drosophila RNAi lines. In 
this way, large-scale synthetic phe-
notypic screens could be conducted 
in Drosophila similar to RNAi screens 
that have proven successful in C. ele-
gans (Lehner et al., 2006).
New Models for Signal Transduction
Recent data demonstrate that extra-
cellular cues are transmitted through 
a dense network of proteins with vari-
able contributions to the network out-
put. The circuit-like signal transduc-
tion models of compartmentalized 
linear pathways (Figure 2A) consisting 
of only a few components have been 
defined as such precisely because of 
the robustness of the developmental 
context in which their organization 
was described. The importance of 
these components as central play-
ers becomes reinforced when they 
are repeatedly used as reagents (in 
epistasis experiments, for exam-
ple) for testing new regulators. Their 
centrality may be further examined 
by proposing that, following their 
disruption, the remaining signaling 
network and its robust character is Cell 128, Jahijacked, producing a developmental 
vector toward a completely abnormal 
morphological endpoint. As we sug-
gested above, analysis or perturba-
tion of this (new) network may reveal 
little about the properties of the origi-
nal wild-type network. The time lags 
(days or weeks) incorporated into 
developmental screens compound 
cascading failure on the timescale of 
intracellular signaling networks as the 
delays allow dramatic network failure 
to be amplified. Therefore, the sim-
ple hierarchical or network structural 
relationships established in a particu-
lar developmental mutant (for exam-
ple, by epistasis) for distantly con-
nected pathway components may be 
questionable.
As opposed to electric circuits, a 
model we favor for signal transduc-
tion (Figure 2B) is that of a gradient 
of quantitative information propa-
gated outward throughout the dense 
protein network following an input 
through an individual receptor. A cen-
tral maximum of information transfer 
can include the old canonical path-
ways (Figure 2C), but the propaga-
tion throughout the signaling network 
may be in part stochastic and influ-
enced by the local network com-
position. Information, usually in the 
form of phosphorylation events, is 
propagated through each protein at 
a particular rate, quantitatively influ-
encing network output, thus requiring 
a dynamic signal transduction model. 
The rates are likely to be highly vari-
able depending on cell type, con-
text, or disease state. Subcellular 
compartmentalization of segments 
of the signaling network can restrict 
information flow to particular sub-
networks. Network architecture and 
feedback control determine how the 
network responds to perturbation: 
removal of a protein through which 
20% of the input signal propagates 
when measured locally may lead to 
compensation through other proteins 
resulting in little change when meas-
ured distantly. The continuous dis-
tribution observed when a network 
measurement is made in cell-based 
screens may be due to a combination 
of the individual protein’s biochemi-
cal activity within the network and the nuary 26, 2007 ©2007 Elsevier Inc. 229
distance in the interactome between 
the knocked-down protein and the 
protein used for the assay. Although 
physical protein-protein interactions 
are the simplest to visualize within 
this model, other interactions (pro-
tein-DNA and protein-RNA) must be 
incorporated to explain isolation of 
particular functional classes (e.g., 
RNA splicing factors) from screens. 
That similar distributions are observed 
in yeast, where gene deletions have 
been used, and in vivo argues against 
degree of knockdown (hypomorphic 
states) as an explanation for the con-
tinuous distributions. However, there 
may be other models that emphasize 
other features to explain current data. 
Although network models of signal 
transduction, in the form of crosstalk, 
are not new, our model incorporates 
a much larger scale and considers 
quantitative contributions of individ-
ual components and network dynam-
ics. We note that this framework con-
trasts drastically with previous views 
recently expressed by some of us 
(Noselli and Perrimon, 2000), reflect-
ing the impact that new methodolo-
gies can have on our thinking.
Although current cell-based path-
way-specific screens do isolate the 
canonical components as the strong-
est regulators, it is important to 
remember that these screens use the 
canonical components as reagents 
(e.g., well-characterized enhancer 
elements for transcriptional report-
ers or phospho-specific antibodies 
directed toward canonical compo-
nent isoforms). Performing unbiased 
screens using noncanonical reagents 
would measure signaling output at 
different points within the network 
and may not necessarily still show 
that the canonical components are 
the strongest regulators following the 
same stimulus.
Given that quantitative unbiased 
screens measuring points within 
the signaling networks have uncov-
ered many new regulators, a major 
challenge going forward will be to 
reconstruct the dynamic structure 
of the networks using computational 
and experimental methodologies. 
Although large-scale, global static 
interaction maps are useful initially 230 Cell 128, January 26, 2007 ©2007 E(for example, Giot et al., 2003; Krogan 
et al., 2006), these rarely recapitulate 
the often transient connections of 
known signaling modules. More help-
ful for understanding signal transduc-
tion networks would be time-depend-
ent experimental and computational 
reconstructions of local signaling 
networks.
Finally, while we argue for re-
contextualizing signal transduction 
within network biology rather than 
canonical pathways, the compari-
son between the findings of sign-
aling RNAi screens and traditional 
developmental screens itself pro-
vides crucial information about the 
origin of developmental robustness. 
If the former provides a much more 
comprehensive picture of local sig-
naling networks, then the failure to 
isolate particular genes from the lat-
ter may suggest the general mecha-
nisms that organisms use to canal-
ize development and explore neutral 
signaling space. Both computational 
(Deutscher et al., 2006) and experi-
mental (Lehner et al., 2006; Ruther-
ford and Lindquist, 1998) approaches 
have already begun such work.
Signaling Networks and Human 
Disease
Changing the language—and experi-
mental approaches—of signal trans-
duction research from cell-circuit 
pathways to network propagation 
impacts how we approach human 
disease and its treatment. Genome-
wide association studies isolating 
common genetic variants that influ-
ence disease susceptibility—quanti-
tative trait loci (QTL)—are essentially 
equivalent to unbiased in vivo genetic 
screens with quantitative readouts, 
such as those in Drosophila observ-
ing effects on bristle number (Norga 
et al., 2003) or wing shape (Dworkin 
and Gibson, 2006). Understanding 
signal transduction from a network 
perspective allows an appreciation of 
how variants of proteins (by mutation 
or concentration) within the network 
can lead to quantitatively different 
outputs. Thus, for diseases known to 
be linked to disruption of particular 
signaling networks, comparison of 
QTLs with functional genomic RNAi lsevier Inc.screens of those networks synergis-
tically provides a mechanistic insight 
into disease etiology. More power-
fully, given that for most diseases the 
underlying cellular mechanisms are 
incompletely known, comprehensive 
searches for enrichment among QTLs 
for genes that regulate particular net-
works (discovered by RNAi screens) 
may help to uncover the underlying 
cellular signaling pathology. As the 
number of quantitative traits from 
these studies starts to soar, ranking 
traits for future analysis and under-
standing their mechanism of action 
will become a necessity.
Cancer research is likely to benefit 
most from a network appreciation of 
signal transduction. Cancer is indica-
tive of both the fragility of ordinarily 
robust signaling networks and is itself 
a robust phenomenon, reflected by the 
paucity of effective treatments (Stell-
ing et al., 2004). Efforts to sequence 
cancer genomes, exemplified by the 
recent proof-of-principle sequencing 
of a large number of genes from breast 
and colorectal cancers (Sjoblom et 
al., 2006), projected an average of 93 
mutated genes per tumor, 17 of which 
are causative, suggesting that many 
mutations are needed to attack the 
robust cell signaling network. It is log-
ical that signal transduction and tran-
scriptional machinery components 
are extremely common functional 
categories mutated in these cancers 
(Sjoblom et al., 2006). Indeed, target-
ing of these hubs through mutations is 
likely to result in dramatic changes in 
network structure. Thus, identification 
of networks for the most common cell 
signals (for example, by RNAi screen-
ing) may help to elucidate the under-
lying reasons these mutations occur 
and how they disrupt robustness. 
Monitoring the signaling networks at 
multiple points and under multiple 
stimuli simulating endogenous sig-
naling can help to predict outcomes 
of mutations and, more importantly, 
responses to treatment by individual 
tumors (Janes et al., 2005). An alter-
native model for cancer, “oncogene 
addiction,” speculates that mutation 
of single genes rather than networks 
of genes may underlie cancer pro-
gression (Weinstein, 2002). Even if 
this model applies in some circum-
stances, network modeling could 
predict “Achilles’ heel” genes in 
addition to a few well-characterized 
oncogenes and predict if targeting of 
these oncogenes could lead to can-
cer regression. Thus, identification of 
the components, contribution, and 
structure of the signaling networks 
through experimental approaches will 
help us to understand how hijacking 
of network robustness by oncogenic 
stimuli buried within the network gen-
erates distinct mutant (carcinogenic) 
outputs and how we can target the 
robustness of tumors to design bet-
ter therapeutics.
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